LAB
Standard Biotools Inc.Company with tickers: LAB
CIK
1162194
CUSIP
34385P108
Shares Outstanding
390,368,119
13F Activity (30d)
138 filings
135 filers
Price
$1.04
Market Cap
$402.08M
P/E Ratio
-5.18
EPS (Diluted)
$-0.20
52W High
$1.72
52W Low
$0.87
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $21,146,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Cost of Revenue | — | ||||
| Gross Profit | $11,308,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Operating Expenses | $23,804,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Research & Development | $2,117,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Operating Income | $-12,496,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Net Income | $127,068,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Basic) | $0.33 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Diluted) | $0.33 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |